Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...
Sickle cell anemia (HbSS) is the homozygous dominant variant and the most common and severe form of the disease. Whereas patients who only inherited one gene encoding for abnormal HbS and a different ...
RICHMOND, Va. — September is National Sickle Cell Awareness Month. Sickle cell affects 100,000 people in the United States, primarily impacting African Americans. To learn more about the genetic blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results